Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013-2015.

The article describes the epidemiological and clinical features of visceral leishmaniasis (VL) cases presented to the three VL treatment centres in Somalia. Topics covered include paromomycin provided by the Drugs for Neglected Diseases initiative in 2015 to implement combination therapy as the first-line treatment, the use of place of residence as a proxy for place of infection, and sodium stilbogluconate as the drug most commonly used in single regimen treatment.